NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

Meirluc, you posted:

I am not mourning the removal of this group from the trial because those patients would have diluted the survival advantage of the Treatment group vis a vis the Controls.

I am afraid that most silver linings come with a cloud.

If they remove the proneural group from the trial and thus improve the likelihood of approval, I am then also afraid that an eventual approval will also not include the proneural group on the label and thus possibly diminish the revenue potential for DCVAX-L which will not be to the liking of investors.